Articles

Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization

Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands;Department of Immuno-hematology and Blood Transfusion, Leiden University Medical Center, the Netherlands
Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands;Department of Immuno-hematology and Blood Transfusion, Leiden University Medical Center, the Netherlands
Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands;Department of Immuno-hematology and Blood Transfusion, Leiden University Medical Center, the Netherlands
Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands;Department of Clinical Epidemiology, Leiden University Medical Center, the Netherlands
Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands;Department of Immuno-hematology and Blood Transfusion, Leiden University Medical Center, the Netherlands;Department of Immunohematology Diagnostics, Sanquin, Amsterdam, the Netherlands
Department of Clinical Chemistry and Hematology, University Medical Center, Utrecht, the Netherlands
Department of Clinical Chemistry and Hematology, Catharina Hospital, Eindhoven, the Netherlands
Department of Hematology, VU Medical Center, Amsterdam, the Netherlands
Department of Clinical Chemistry and Hematology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, the Netherlands
LabWest, Haga Teaching Hospital, The Hague, the Netherlands
Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands;Department of Clinical Epidemiology, Leiden University Medical Center, the Netherlands
Vol. 102 No. 1 (2017): January, 2017 https://doi.org/10.3324/haematol.2016.152074